NCT02316054View on ClinicalTrials.gov

Evaluation of Myocardial Perfusion Heterogeneity Imaging in Diabetes Patients (EVADIAB)

CompletedOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Type 2 Diabetes
Interventions
DEVICE

MPHI

addictive value of MPHI to management of high risk cardiovascular type 2 diabetes

Trial Locations (1)

38000

university Hospital, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT02316054 - Evaluation of Myocardial Perfusion Heterogeneity Imaging in Diabetes Patients (EVADIAB) | Biotech Hunter | Biotech Hunter